The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
Abstract
Intravenous immune globulin has been used in the treatment of primary and secondary antibody deficiencies for more than 25 years. It is a safe preparation with no long-term side effects. Intravenous immune globulin was first demonstrated to be effective in an autoimmune disorder — idiopathic thrombocytopenic purpura — two decades ago. Since then, it has been established to be efficacious in the treatment of the Guillain–Barré syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, corticosteroid-resistant dermatomyositis, and Kawasaki's syndrome and in the prevention of graft-versus-host disease in recipients of allogeneic bone marrow transplants. Benefits have been reported in many other autoimmune . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’
Avrameas, S. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80045-3 · Cited by 766
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Cited by
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
Consiglio, C. R., Cotugno, N., Sardh, F., Pou, C., Amodio, D., Rodriguez, L., Tan, Z., Zicari, S., Ruggiero, A., Pascucci, G. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.016 · Cited by 919
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Li, H., Zuo, J., & Tang, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01048 · Cited by 580
Jordan, S. C., Tyan, D., Stablein, D., McIntosh, M., Rose, S., Vo, A., Toyoda, M., Davis, C., Shapiro, R., Adey, D., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145878.92906.9f · Cited by 435
Moving towards personalized treatments of immune-related adverse events
Esfahani, K., Elkrief, A., Calabrese, C., Lapointe, R., Hudson, M., Routy, B., Miller, W. H., & Calabrese, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0352-8 · Cited by 351
Unravelling the Complexity of T Cell Abnormalities in Common Variable Immunodeficiency
Giovannetti, A., Pierdominici, M., Mazzetta, F., Marziali, M., Renzi, C., Mileo, A. M., De Felice, M., Mora, B., Esposito, A., Carello, R., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3932 · Cited by 273
Metadata
- Authors
- Kazatchkine, M. D., & Kaveri, S. V.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-09-06
- Volume
- 345
- Issue
- 10
- Pages
- 747-755
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2616639792
- Cited by
- 1,209
- References
- 2
- FWCI
- 18.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin. https://app.cochat.ai/papers/10.1056/nejmra993360
- The paper
- Kazatchkine, M. D., & Kaveri, S. V. (2001). Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin. New England Journal of Medicine. https://doi.org/10.1056/nejmra993360
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
